Skip to main content
NRXP
NASDAQ Life Sciences

NRx Pharmaceuticals Sued for Breach of Contract, Alleged Misrepresentation in Acquisition

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.71
Mkt Cap
$155.61M
52W Low
$1.62
52W High
$5.055
52W Position info
129% above low
Off High info
27% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

NRXP has more than doubled off its 52-week low of $1.62 on light trading volume (0.2× avg).

Summary

Kadima Neuropsychiatry Institute has filed a lawsuit against NRx Pharmaceuticals, alleging breach of contract and misrepresentation related to an acquisition. The suit claims NRx warranted it had funds to close the deal while concealing a lack of committed financing. This follows NRx's recent Q1 'going concern' warning and a dilutive $22.3 million public offering in early June. The lawsuit seeks specific performance, which could force the company to complete a deal it may not be able to finance, adding significant legal and financial risk to a company already facing liquidity challenges.

At the time of this announcement, NRXP was trading at $3.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $155.6M. The 52-week trading range was $1.62 to $5.06. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

NRXP - Latest Insights

NRXP
Nov 17, 2026, 7:18 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.10
Real-time Price: $2.20 info
Change: +$0.100 (+5%) info
Market Cap: $94.058M info
NRXP
Oct 30, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $2.20 info
Change: -$0.7798 (-26%) info
Market Cap: $94.058M info
NRXP
Oct 15, 2026, 8:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.55
Real-time Price: $2.20 info
Change: -$0.350 (-14%) info
Market Cap: $94.058M info
NRXP
Oct 05, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.86
Real-time Price: $2.20 info
Change: -$0.660 (-23%) info
Market Cap: $94.058M info
NRXP
Sep 30, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.98
Real-time Price: $2.20 info
Change: -$0.7845 (-26%) info
Market Cap: $94.058M info